(Allergan plc)

	AGN latest price $158.6214 (-2.19%) ($156.9323 - $161.0569) on Fri. Apr. 6, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.08% (three month average)
RSI	39
Latest Price	$158.6214(-2.19%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.8% a day on average for past five trading days.
Weekly Trend	AGN declines -0.2% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(51%)    XLV(49%)    XBI(47%)    ARKG(45%)    IVW(45%)
Factors Impacting AGN price	AGN will decline at least -1.04% in a week (0% probabilities).   VIXM(-28%)    TLT(-20%)    UUP(-18%)    DIA(-7%)    GDXJ(-6%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.04% (StdDev 2.08%)
Hourly BBV	0 ()
Intraday Trend	-1.5%

Resistance Level	$160.66
5 Day Moving Average	$161.08(-1.53%)
10 Day Moving Average	$160.56(-1.21%)
20 Day Moving Average	$160.66(-1.27%)
To recent high	-13.8%
To recent low	12.2%
Market Cap	$52.297b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed